Amalgamated Bank’s CervoMed CRVO Stock Holding History

Amalgamated Bank’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-187	Closed	-$2K	–	3039
2025 Q1	$2K	Hold	187	–	–	﹤0.01%	2833
2024 Q4	$0	Hold	187	–	–	﹤0.01%	2976
2024 Q3	$3K	Hold	187	–	–	﹤0.01%	2868
2024 Q2	$3K	Buy	+187	New	+$4.09K	﹤0.01%	2910

Other funds holding CRVO

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return

AAS

Avantax Advisory Services Dallas, Texas $18.2B AUM 15.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amalgamated Bank's CRVO Position: Q2 2025 in Review

Amalgamated Bank sold out of CervoMed (CRVO) in Q2 2025, closing a stake of 187 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in CRVO in Q2 2024 and held it in 4 quarters. The position peaked at $3K in Q3 2024. 45 funds tracked by Wall St. Rank hold CRVO as of Q2 2025.

Amalgamated Bank reported no remaining CervoMed position as of Q2 2025 after selling out during the quarter.
Amalgamated Bank sold 187 CervoMed shares in Q2 2025, an estimated $2K.
Amalgamated Bank first reported a position in CervoMed in Q2 2024 and held it in 4 quarters.
Amalgamated Bank's CervoMed position peaked at $3K in Q3 2024.
45 funds tracked by Wall St. Rank held CervoMed as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.